The effects of pharmacological androgen reduction or androgen receptor antagonists on insulin sensitivity have been less consistent (63); however, Mendelian randomization in a population-based study has supported a causal link between hyperandrogenemia and both PCOS and type 2 diabetes (64). The gene discussed is INS; the disease is type 2 diabetes mellitus.